Get Started

MGNX

NASD MacroGenics, Inc.
Nov 4, 2026 · 11:34 PM ET EOD Market Closed

$2.31 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.31, $0.15 below the day’s high of $2.46

YTD change
+43.48%
vs 20-day SMA
-23.94%
vs 200-day SMA
-32.53%

Price ranges

Previous day
$2.26 $2.49
open $2.36 close $2.33
-$0.03 (-1.27%)
Today
$2.23 $2.46
open $2.39 now $2.31
-$0.08 (-3.35%)
Past week
$2.24 $2.59
from $2.44 now $2.31
-$0.13 (-5.33%)
Past month
$1.93 $3.79
from $3.64 now $2.31
-$1.33 (-36.54%)
This year
$1.58 $5.08
from $1.61 now $2.31
+$0.70 (+43.48%)

Price & Performance

-0.89 (-27.81%) / 6M

$1.98$3.01$4.04$5.07May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 93.7% away from all-time highs of $36.48
  • MGNX is up 43% since the beginning of the year
  • MGNX is up 59% over the past 12 months
  • MGNX is down 37% over the past 1 month
  • 10% of all MGNX investors are betting against MGNX

MGNX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +59.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.31
Earnings momentum +198.4% Quarterly EPS growth
Quarterly change +198.4%

Valuation

P/E ratio N/A
Enterprise value $173.1M
Beta 0.71

Balance sheet & scale

IncomeN/A
Revenue$153.6M
Cash$173.3M
Debt$198.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $147.1M

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.